Buy Zydus Wellness; target of Rs 2300: Sharekhan

Sharekhan's research report on Zydus Wellness

The company is raising ~Rs. 1,100 crore through QIP/preferential allotment to promoter, which will be utilised to reduce debt. Reduction in debt would lead to cost savings of Rs. 90-100 crore, which would result in strong EPS accretion in FY2022-23. It has identified three pillars of growth from a medium to long-term perspective: driving synergistic benefits from Heinz deal, new launches and expanding international footprint. The three pillars strategy could help company to achieve earnings CAGR of 27% over FY2020-23 (with OPM expanding by 180 bps).

Outlook

We re-iterate a Buy rating on Zydus Wellness (ZWL) with a revised price target of Rs. 2,300. Negative working capital, focus on strengthening balance sheet and strong earnings visibility makes ZWL a best pick in mid-cap FMCG space.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More